Preparation method of compound tert-butyl methyl (3-ketocyclobutyl) carbamate as medical intermediate
By oxidation reaction using oxalyl chloride activated dimethyl sulfoxide in the presence of organic base, tert-butyl methyl (3-ketocyclobutyl)carbamate was successfully prepared, solving the simplicity of the preparation method in the prior art. and industrial applicability issues, efficient compound synthesis has been achieved.
Patent Information
- Application Number
- CN202411038342.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-31
- Publication Date
- 2024-11-15
AI Technical Summary
No effective preparation method for tert-butyl methyl (3-ketocyclobutyl)carbamate is seen in the prior art, and there is a lack of a simple and suitable process for industrial production.
The target compound was prepared by using tert-butyl (3-hydroxycyclobutyl)(methyl)carbamate as raw material, and using oxalyl chloride activated dimethyl sulfoxide as oxalyl chloride as the oxidant.
It has achieved efficient synthesis of tert-butyl methyl (3-ketocyclobutyl) carbamate, with simple process, less equipment investment, easy to control reaction conditions, and strong process feasibility.
Smart Images

Figure CN118955332A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of pharmaceutical intermediate synthesis, and in particular to a method for preparing tert-butyl methyl (3-ketocyclobutyl) carbamate, a compound used as a pharmaceutical intermediate. Background Art
[0002] Tert-butyl methyl (3-ketocyclobutyl) carbamate is an important pharmaceutical intermediate, mainly used in the synthesis of new drugs, such as the synthesis of BTK inhibitors in patent document WO2022104079 and the synthesis of lipase regulators in patent document WO2021191391. There are currently no reports on the development and production of tert-butyl methyl (3-ketocyclobutyl) carbamate. Summary of the invention
[0003] In response to the above technical problems, the present application provides a method for preparing tert-butyl methyl (3-ketocyclobutyl) carbamate using tert-butyl (3-hydroxycyclobutyl)(methyl) carbamate as a raw material. The method has the advantages of simple operation, mild reaction and can be applied to industrial production.
[0004] In order to achieve the above-mentioned purpose, the technical scheme adopted in the present application is: a method for preparing tert-butyl methyl (3-ketocyclobutyl) carbamate, a compound used as a pharmaceutical intermediate, using tert-butyl (3-hydroxycyclobutyl) (methyl) carbamate as the main raw material and dimethyl sulfoxide activated by oxalyl chloride as the oxidant, and obtaining the target compound through an oxidation reaction in the presence of an organic base.
[0005] In order to better realize the present invention, further, the oxidation reaction of tert-butyl 3-hydroxycyclobutyl) (methyl) carbamate is carried out in the presence of dimethyl sulfoxide activated by oxalyl chloride.
[0006] In order to better realize the present invention, further, the organic base is selected from one of triethylamine and N,N-diisopropylethylamine.
[0007] The beneficial effects of the present invention are as follows: the present invention designs a new method for synthesizing tert-butyl methyl (3-ketocyclobutyl) carbamate, takes (3-hydroxycyclobutyl) (methyl) carbamate as a raw material, and obtains the target compound tert-butyl methyl (3-ketocyclobutyl) carbamate through a mild oxidation reaction, the process is simple, the equipment investment is small, the reaction conditions are easy to control, and the process has strong feasibility of process scale-up. BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 The schematic diagram of the synthesis of tert-butyl methyl (3-ketocyclobutyl) carbamate of the present invention; DETAILED DESCRIPTION
[0008] In order to make the objectives, technical solutions and beneficial effects of the present invention more clear, preferred embodiments of the present invention will be described in detail below.
[0009]
[0010] To a 5000 ml three-necked flask, 127.1 g of oxalyl chloride and 2070 g of dichloromethane were added in sequence, 156.5 g of dimethyl sulfoxide was added dropwise at -10°C to 0°C, and the mixture was stirred at -10°C for 10 minutes after the addition was completed. Then, a solution of 140 g of compound A and 300 g of dichloromethane was added dropwise at -10°C to -5°C, and the mixture was stirred at -10°C for 20 minutes after the addition was completed. Then, 380.4 g of triethylamine was added dropwise at -10°C to -5°C, and the mixture was stirred at -10°C for 20 minutes after the addition was completed. The mixture was stirred at room temperature for 1 hour, 2000 g of water was added, stirred, and the layers were separated. The organic layer was then washed with 3000 g of saturated sodium chloride three times, and the organic layer was dried with 500 g of anhydrous sodium sulfate, concentrated to obtain a crude product, and recrystallized with ethyl acetate and petroleum ether to obtain 49 g of a pure product.
[0011] The above description is only the preferred embodiment of the present application and is not intended to limit the present application. For those skilled in the art, the present application may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application shall be included in the protection scope of the present application.
Claims
1. A method for preparing tert-butyl methyl (3-ketocyclobutyl) carbamate as a pharmaceutical intermediate, characterized in that: The target compound is obtained by oxidation reaction in the presence of an organic base using (3-hydroxycyclobutyl)(methyl)carbamic acid tert-butyl ester as the main raw material and dimethyl sulfoxide activated by oxalyl chloride as the oxidant:
2. A method for preparing a compound tert-butyl methyl (3-ketocyclobutyl) carbamate as a pharmaceutical intermediate according to claim 1, characterized in that: The oxidation reaction of the compound of the formula tert-butyl (3-hydroxycyclobutyl)(methyl)carbamate is carried out in the presence of dimethyl sulfoxide activated with oxalyl chloride.
3. A method for preparing a compound tert-butyl methyl (3-ketocyclobutyl) carbamate as a pharmaceutical intermediate according to claim 1, characterized in that: The organic base is selected from one of triethylamine and N,N-diisopropylethylamine.
Citation Information
Patent Citations
Preparation method of tert-butyl 3-oxocyclobutyl carbamate
CN111848423A
Pyrazolo [1, 5-a] pyrazine derivatives as btk inhibitors
CN116783199A
Stereoselective Synthesis of Amino Acid Analogs for Tumor Imaging
US20060292073A1
Compounds for use as bradykinin b1 antagonists
WO2010097374A1
